Evidence map›Paper›PMID 40832039›Full record

ArticleFrontiers in public health2025

Decadal trends and regional disparities in tuberculosis burden: a comprehensive analysis of global, African, and Southeast Asian data from the GBD 1990-2021.

Shiwei Xie, Heng Xiao, Lei Xu, Fan Zhang, Mingwei Luo

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Applying Multiple Analyses to Quantify Changes in the Global, Regional, and National Burden of Tuberculosis From 1990 to 2021 and the Forecast Until 2035.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiwei XiePanzhihua Central Hospital, Panzhihua, Sichuan, China.
Heng XiaoPanzhihua Central Hospital, Panzhihua, Sichuan, China.
Lei XuPanzhihua Central Hospital, Panzhihua, Sichuan, China.
Fan ZhangDepartment of Orthopedic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Mingwei LuoPanzhihua Central Hospital, Panzhihua, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis (TB), an infectious disease caused by Methods: Data from the Global Burden of Disease 2021 (GBD 2021) study were used to evaluate TB incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021. Statistical analyses were conducted using R software and Joinpoint Regression Program to identify trends in age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR). The annual percentage change (APC) was calculated to assess the significance of temporal trends. Results: From 1990 to 2021, global age-standardized rates of TB declined markedly, with ASIR decreasing from 173.0 to 103.0 per 100,000, ASMR from 40.0 to 14.0, and ASDR from 1,650.6 to 580.3. Although incident case numbers slightly declined globally, absolute numbers increased in Africa and Southeast Asia, despite reductions in standardized rates. The disease burden has shifted from younger to older age groups, reflecting population aging. Males consistently exhibited a higher burden than females, though sex disparities narrowed over time. Joinpoint regression confirmed sustained declines in all indicators, particularly in Africa and Southeast Asia. Projections to 2040 suggest continued reductions and convergence in burden across regions. Spatial analyses identified persistent high-burden clusters in sub-Saharan Africa and Southeast Asia, despite overall global improvement. Conclusion: TB remains a significant public health issue, especially in Africa and Southeast Asia. While global incidence and mortality have decreased, persistent regional disparities call for more targeted interventions. Ongoing global efforts are essential to further reduce TB-related morbidity and mortality.

Indexed as

Global Burden of DiseaseGlobal HealthTuberculosisAdolescentAdultAfricaAsia, SoutheasternCost of IllnessDisability-Adjusted Life YearsFemaleHumansIncidenceMaleMiddle AgedPrevalenceYoung Adultdisability-adjusted life yearsglobal burden of diseaseincidencemortalitytuberculosis

Identifiers

PMID40832039
PMCPMC12358351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.